Exponent, Inc. (NASDAQ:EXPO – Get Free Report) CEO Catherine Corrigan sold 1,707 shares of Exponent stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $66.28, for a total value of $113,139.96. Following the completion of the sale, the chief executive officer owned 129,108 shares of the company’s stock, valued at $8,557,278.24. This trade represents a 1.30% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Catherine Corrigan also recently made the following trade(s):
- On Monday, June 15th, Catherine Corrigan sold 4,119 shares of Exponent stock. The stock was sold at an average price of $57.13, for a total transaction of $235,318.47.
Exponent Stock Performance
EXPO opened at $67.51 on Wednesday. The company’s 50 day simple moving average is $62.15 and its 200 day simple moving average is $64.59. Exponent, Inc. has a 1 year low of $51.91 and a 1 year high of $81.95. The stock has a market capitalization of $3.21 billion, a PE ratio of 30.27 and a beta of 0.68.
Exponent Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 18th. Stockholders of record on Friday, September 4th will be issued a dividend of $0.31 per share. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date is Friday, September 4th. Exponent’s dividend payout ratio is presently 55.61%.
Hedge Funds Weigh In On Exponent
Several hedge funds and other institutional investors have recently made changes to their positions in EXPO. Bell Investment Advisors Inc increased its holdings in Exponent by 423.6% in the 1st quarter. Bell Investment Advisors Inc now owns 377 shares of the business services provider’s stock valued at $25,000 after purchasing an additional 305 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in shares of Exponent in the second quarter worth about $26,000. Allworth Financial LP boosted its position in shares of Exponent by 86.1% in the fourth quarter. Allworth Financial LP now owns 469 shares of the business services provider’s stock worth $33,000 after buying an additional 217 shares during the period. Public Employees Retirement System of Ohio purchased a new stake in shares of Exponent in the second quarter worth about $29,000. Finally, Bessemer Group Inc. grew its stake in shares of Exponent by 37.1% in the first quarter. Bessemer Group Inc. now owns 717 shares of the business services provider’s stock valued at $47,000 after buying an additional 194 shares in the last quarter. Institutional investors and hedge funds own 92.37% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of brokerages recently weighed in on EXPO. Weiss Ratings reiterated a “hold (c-)” rating on shares of Exponent in a report on Friday, July 17th. UBS Group set a $72.00 price target on Exponent and gave the stock a “neutral” rating in a research note on Friday, July 31st. Finally, JPMorgan Chase & Co. raised their price objective on Exponent from $80.00 to $90.00 and gave the stock an “overweight” rating in a report on Friday, July 31st. Two equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $81.00.
Check Out Our Latest Stock Analysis on EXPO
About Exponent
Exponent, Inc (NASDAQ: EXPO) is an engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries. The company’s expertise spans mechanical, materials and corrosion engineering, civil and structural engineering, electrical engineering, industrial hygiene, toxicology and health sciences, and failure analysis. Exponent provides support for product design, performance evaluation, litigation consulting, and regulatory compliance, helping manufacturers, insurers, law firms and government agencies address complex technical challenges.
Founded in 1967 in Menlo Park, California, Exponent has grown from a small failure-analysis laboratory into a global consulting practice.
Featured Articles
- Five stocks we like better than Exponent
- The AI Boom Is Turning This Cable Maker Into a Stock to Watch
- A Star Investor Just Trimmed Amazon—Here’s What It means
- Wendy’s Deal Buzz May Give Fast-Food Investors a New Reason to Look
- Home Depot Analysts See a Path to $375 and Beyond
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.
